N@N

Market Maker Surveillance Report. BTH, IF, EGLE, AFFY, BPAX, ONTY, Losing Stocks With Lowest Price Friction For Wednesday, Dec

December 19, 2012 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 4042 companies with "abnormal" market making, 2681 companies with positive Friction Factors and 2928 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Wednesday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Blyth Inc (NYSE:BTH), Aberdeen Indonesia Fund Inc (AMEX:IF), Eagle Bulk Shipping Inc (NASDAQ:EGLE), Affymax Inc (NASDAQ:AFFY), BioSante Pharmaceuticals Inc (NASDAQ:BPAX), Oncothyreon Inc (NASDAQ:ONTY). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  BTH     $-2.160   -11.66%   571,616      33.16%    645,956      37.47%    -74,340      -344    
  IF      $-2.220   -15.72%   33,246       14.71%    46,904       20.76%    -13,658      -62     
  EGLE    $-0.210   -12.66%   314,279      25.80%    511,741      42.01%    -197,462     -9,403  
  AFFY    $-2.790   -12.51%   1,594,987    44.75%    1,867,831    52.41%    -272,844     -978    
  BPAX    $-0.220   -14.41%   798,088      39.39%    1,219,881    60.21%    -421,793     -19,172 
  ONTY    $-2.300   -51.11%   15,561,080   47.56%    16,978,162   51.90%    -1,417,082   -6,161  

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net dollar losses (Change) and extremely low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows BTH with a dollar loss Wednesday of $-2.16000 and a Friction Factor of -344 shares. That means that it only took 344 more shares of selling than buying to move BTH lower by one penny. This means the Market Makers are allowing the stock to drop quickly (low friction). The combination of low friction and negative market direction can drive prices lower faster than normal.

Blyth Inc (NYSE:BTH) - Blyth, Inc., together with its subsidiaries, operates as a multi-channel company focusing on the direct to consumer market. It operates in three segments: Direct Selling, Catalog & Internet, and Wholesale. The Direct Selling segment designs, manufactures or sources, markets, and distributes a line of products, including scented candles, candle-related accessories, and other fragranced products under the PartyLite brand name. It also offers gourmet foods under the Two Sisters Gourmeta, as well as operates ViSalus Sciences, a direct selling business that focuses on selling meal replacement shakes, weight management products, nutritional supplements, snack cookies, and energy drinks. This segment sells its products through networks of independent sales consultants and promoters. The Catalog & Internet segment designs, sources, and markets a range of household convenience items, health and wellness products, holiday cards, personalized gifts, kitchen accessories, photo albums, and frames. This segment sells its products directly, as well as through catalog and Internet distribution channels under the brand names of As We Change, Easy Comforts, Exposures, Miles Kimballa, and Walter Drakea. The Wholesale segment designs, manufactures or sources, markets, and distributes chafing fuel and tabletop lighting products and accessories for the away from home or foodservice trade under the Ambria, HandyFuel, and Sterno brand names. This segment serves mass retailers, foodservice distributors, hotels, and restaurants. Blyth, Inc. was founded in 1976 and is headquartered in Greenwich, Connecticut..

Aberdeen Indonesia Fund Inc (AMEX:IF) - THE INDONESIA FUND.

Eagle Bulk Shipping Inc (NASDAQ:EGLE) - Eagle Bulk Shipping Inc. engages in the ocean transportation of bulk cargoes in the dry bulk industry. The company primarily transports iron ore, coal, grain, cement, and fertilizer along worldwide shipping routes. As of December 31, 2009, it owned and operated a fleet of 27 oceangoing vessels with a combined carrying capacity of 1,412,535 deadweight tons. The company was founded in 2005 and is headquartered in New York, New York..

Affymax Inc (NASDAQ:AFFY) - Affymax, Inc., a biopharmaceutical company, engages in the development of drugs for the treatment of serious and life-threatening conditions. The company is developing Hematide, which is in Phase III clinical trials for the treatment of anemia associated with chronic renal failure. Hematide is a synthetic peptide-based erythropoiesis stimulating agent designed to stimulate production of red blood cells. Affymax, Inc. has strategic alliance agreements with Takeda Pharmaceutical Company Limited and Nektar Therapeutics AL, Corporation to manufacture, develop, and commercialize Hematide. The company was founded in 2001 and is based in Palo Alto, California..

BioSante Pharmaceuticals Inc (NASDAQ:BPAX) - BioSante Pharmaceuticals, Inc., a specialty pharmaceutical company, develops products for female sexual health and oncology. Its lead products include LibiGel (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD), which is in Phase III clinical development under a U.S. Food and Drug Administration (FDA) special protocol assessment; and Elestrin (estradiol gel) for the treatment of moderate-to-severe vasomotor symptoms associated with menopause, which is marketed in the U.S. by Azur Pharma, BioSantes licensee. The company is also developing a portfolio of cancer vaccines, three of which have been granted orphan drug designation, and are currently in various Phase II clinical trials. Its other products in development comprise Bio-T-Gel, a testosterone gel for male hypogonadism, or testosterone deficiency in men, which is licensed to Teva Pharmaceuticals; and The Pill-Plus that is a combination of estrogens, progestogens, and androgens for the treatment of female sexual dysfunction in women using oral or transdermal contraceptives, in Phase II clinical development using BioSante patented technology. In addition, the company is developing its calcium phosphate technology for aesthetic medicine, as well as seeking opportunities for its 2A/Furin and other technologies. BioSante Pharmaceuticals, Inc. was founded in 1996 and is based in Lincolnshire, Illinois..

Oncothyreon Inc (NASDAQ:ONTY) - Oncothyreon Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic products for the treatment of cancer. Its primary product candidate, Stimuvax is in two phase III clinical trials for the treatment of non-small cell lung cancer. The company is also developing PX-866, a small molecule that is in phase II trials for various cancer indications. In addition, it engages in the preclinical development of ONT-10, a cancer vaccine; and ONT-701, a pan-inhibitor of the B-cell lymphoma-2 family of anti-apoptotic proteins. The company operates primarily in the United States and Canada. Oncothyreon Inc. was founded in 1985 and is headquartered in Seattle, Washington..

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net